GovWire

Guidance: International Recognition Procedure

Medicines Healthcare Products Regulatory Agency

December 20
16:02 2023

Details

Eligibility checker

Fill in the Eligibility Checker form.

Please see our guidance before completing the above form.

You may also find it of benefit to review the full list of questions, which includes some guidance, before completing the form.

Please liaise with your IT department to ensure you can save PDFs before completing the form.

The MHRA has created a new international recognition route for medicines utilising pre-existing approvals from Australia, Canada, the European Union, Japan, Switzerland, Singapore and the United States. This new framework will support patients in the UK with expedited access to safe and effective medicines that have been approved by trusted regulatory partners. From 1 January 2024, international recognition will sit alongside the MHRAs current national procedures.

Webinar

The MHRA webinar provided potential applicants with the opportunity to increase their knowledge and understanding of the guidance on the International Recognition Procedure.

MHRA International Recognition Webinar November 2023

Published 30 August 2023
Last updated 20 December 2023

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: